Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)
Status:
Completed
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
The study will investigate the PK and safety of evobrutinib in subjects with different degree
of renal impairment as compared to subjects with normal renal function.